Andrew L. Frelinger

Also affiliated with Dana-Farber/Boston Children's Cancer and Blood Disorders Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Biomarkers of platelet activation and cardiovascular risk in the DAPT trial”.

Biomarkers of platelet activation and cardiovascular risk in the DAPT trial

Journal of Thrombosis and Thrombolysis(2020)10.1007/s11239-020-02221-5

N/A

0.721DataRank · unranked

14 citations

Robert W. Yeh, Laura Mauri, David A. Morrow, Dean J. Kereiakes, Donald E. Cutlip +8 more

Inhibition of transcription factor NFAT activity in activated platelets enhances their aggregation and exacerbates gram-negative bacterial septicemia

Immunity(2022)10.1016/j.immuni.2021.12.002

N/A

0DataRank · unranked

32 citations

Marco Di Gioia, Martha Sola‐Visner, Francesca Granucci, Andrew L. Frelinger, Alan D. Michelson +2 more

Flow Cytometry and Platelets

Clinics in Laboratory Medicine(2024)10.1016/j.cll.2024.04.011

N/A

0DataRank · unranked

5 citations

Andrew L. Frelinger